$TLGT on NASDAQ
October 14, 2021
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process
August 16, 2021
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
August 11, 2021
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021
June 30, 2021
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
June 18, 2021
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
May 25, 2021
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update
May 21, 2021
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
May 03, 2021
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
April 15, 2021
Teligent Announces Hiring of Chief Financial Officer
February 23, 2021
Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors
February 16, 2021
Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors
January 28, 2021
Teligent Takes Strategic Steps to Recapitalize and Position Business for Success
January 22, 2021
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule
December 31, 2020
Teligent, Inc. Announces Third Quarter 2020 Results
November 25, 2020
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
November 11, 2020
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
October 22, 2020
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
September 23, 2020
Teligent Announces Completion of Series D Convertible Note Exchange
August 19, 2020
Teligent, Inc. Announces Second Quarter 2020 Results
August 14, 2020
Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday August 19th, 2020
July 20, 2020
Teligent Announces Completion of Series C Convertible Note Financing and Exchange
July 20, 2020
Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board
July 17, 2020
Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary
June 22, 2020
Teligent Regains Compliance with NASDAQ Listing Requirements
June 03, 2020
Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 and its 4.75% Convertible Senior Notes Due 2023
May 26, 2020
Teligent Announces One-for-Ten Reverse Stock Split
May 22, 2020
Teligent, Inc. Announces First Quarter 2020 Results
May 19, 2020
Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020
April 08, 2020
TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES
April 03, 2020
Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020
February 05, 2020
Teligent, Inc. Announces Transition in Leadership
December 23, 2019
Teligent, Inc. Announces FDA Request for Further Data on Complex Drug
November 13, 2019
Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019
November 04, 2019
Teligent, Inc. Announces Third Quarter 2019 Results
October 31, 2019
Teligent, Inc. to Hold Conference Call for Third Quarter 2019 Results on Monday November 4th, 2019
October 28, 2019
Teligent Announces the Pricing of $34.4 Million of Series B Senior Convertible Notes
October 28, 2019
Teligent Announces First Injectable Filing From New Manufacturing Facility
October 18, 2019
Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Cream USP, 0.1% (Gentamicin Base)
October 01, 2019
Teligent Announces Strategic Review
August 05, 2019
Teligent, Inc. Announces Second Quarter 2019 Results
August 01, 2019
Teligent, Inc. to Hold Conference Call for Second Quarter 2019 Results on Monday August 5th, 2019
June 18, 2019
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
June 18, 2019
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
May 06, 2019
Teligent, Inc. Announces First Quarter 2019 Results
May 02, 2019
Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019
April 22, 2019
Teligent Provides Update on Orphan Drug Complete Response Letter
April 12, 2019
Teligent, Inc. Management Comments on Recent Market Movements
April 04, 2019
Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.1%
March 19, 2019
Teligent, Inc. Announces FDA Approval of Fluocinonide Topical Solution USP, 0.05%
March 18, 2019
Teligent, Inc. Announces Fourth Quarter and Year End 2018 Results
- No Recent Filings Found.
